Your browser doesn't support javascript.
loading
Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.
Papa, Anselmo; Zaccarelli, Eleonora; Caruso, Davide; Vici, Patrizia; Benedetti Panici, Pierluigi; Tomao, Federica.
Afiliación
  • Papa A; a Department of Medico-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Oncology Unit , Istituto Chirurgico Ortopedico Traumatologico , 04100 Latina , Italy.
  • Zaccarelli E; a Department of Medico-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Oncology Unit , Istituto Chirurgico Ortopedico Traumatologico , 04100 Latina , Italy.
  • Caruso D; a Department of Medico-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Oncology Unit , Istituto Chirurgico Ortopedico Traumatologico , 04100 Latina , Italy.
  • Vici P; b Division of Medical Oncology B , Regina Elena National Cancer Institute , 00144 Rome , Italy.
  • Benedetti Panici P; c Department of Gynecological, Obstetrical and Urologic Sciences , "Sapienza" University of Rome , 00186 Rome , Italy.
  • Tomao F; c Department of Gynecological, Obstetrical and Urologic Sciences , "Sapienza" University of Rome , 00186 Rome , Italy.
Expert Opin Investig Drugs ; 25(1): 31-49, 2016.
Article en En | MEDLINE | ID: mdl-26560489

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Inhibidores de la Angiogénesis / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Expert Opin Investig Drugs Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2016 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Inhibidores de la Angiogénesis / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Expert Opin Investig Drugs Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2016 Tipo del documento: Article País de afiliación: Italia
...